ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,079Medicare Part D Prescriptions Filled, Including Refills

Rank: 159 out of 1000

$838K Total Retail Price of All Prescriptions

Rank: 92 out of 1000

645 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 645 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 645 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 7,775 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 643 380 1 3
OMEPRAZOLE 558 342 2 2
AMLODIPINE BESYLATE 475 311 3 6
FUROSEMIDE 356 170 4 7
METFORMIN HCL 340 197 5 8
HYDROCODONE-ACETAMINOPHEN 337 169 S3 6 1
LISINOPRIL 250 157 7 5
HYDROCHLOROTHIAZIDE 222 126 8 9
ATORVASTATIN CALCIUM 200 116 9 18
CARVEDILOL 193 122 10 15
CLONIDINE HCL 185 113 11 27
GABAPENTIN 179 86 12 11
LEVOTHYROXINE SODIUM 176 106 13 4
ZOLPIDEM TARTRATE 173 60 14 16
POTASSIUM CHLORIDE 172 93 15 10
PRAVASTATIN SODIUM 160 81 16 12
GLYBURIDE-METFORMIN HCL 160 99 R 16 121
MELOXICAM 154 110 18 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 144 83 19 20
NEXIUM 140 63 20 23
LOSARTAN POTASSIUM 138 83 21 25
TAMSULOSIN HCL 137 107 22 33
DONEPEZIL HCL 135 124 23 32
TRAMADOL HCL 129 50 24 13
LOSARTAN-HYDROCHLOROTHIAZIDE 125 77 25 38
DIOVAN HCT 123 92 26 96
KLOR-CON M20 122 90 27 66
IBUPROFEN 110 60 28 94
ESCITALOPRAM OXALATE 109 35 29 60
SINGULAIR 105 56 30 84
CYCLOBENZAPRINE HCL 102 24 R 31 39
SERTRALINE HCL 101 41 32 26
ATENOLOL 101 54 32 24
METOPROLOL TARTRATE 100 54 34 19
NAPROXEN 100 37 34 81
QUINAPRIL HCL 97 57 36 117
INSULIN SYRINGE 87 55 37 93
GLIMEPIRIDE 84 56 38 34
POLYETHYLENE GLYCOL 3350 83 34 39 69
FLUTICASONE PROPIONATE 83 44 39 40
CARISOPRODOL 82 26 R 41 72
PANTOPRAZOLE SODIUM 82 34 41 28
CLOPIDOGREL 79 61 43 35
METOCLOPRAMIDE HCL 78 45 44 99
RANITIDINE HCL 77 45 45 37
PLAVIX 77 66 45 49
ALLOPURINOL 75 35 47 31
ACARBOSE 74 34 48 268
COLCRYS 73 34 49 171
CRESTOR 73 52 49 30
NAMENDA 73 70 49 43
AMITRIPTYLINE HCL 72 16 R 52 45
METOPROLOL SUCCINATE 72 41 52 21
QUETIAPINE FUMARATE 72 29 52 75
FOSINOPRIL SODIUM 71 68 55 154
MIRTAZAPINE 70 43 56 56
METFORMIN HCL ER 70 28 56 44
VERAPAMIL ER 65 53 58 86
PROAIR HFA 64 37 59 50
GLIPIZIDE 64 44 59 62
DIOVAN 63 43 61 67
ALENDRONATE SODIUM 63 46 61 57
LYRICA 62 26 63 47
LOVASTATIN 62 51 63 41
ACTOS 61 48 65 119
INDOMETHACIN 61 29 R 65 246
PHENYTOIN SODIUM EXTENDED 59 22 67 115
DIGOXIN 59 41 67 52
MECLIZINE HCL 57 49 69 80
HUMULIN 70-30 56 35 70 131
SPIRONOLACTONE 56 21 70 78
TRAZODONE HCL 55 22 72 29
BUSPIRONE HCL 55 30 72 110
ADVAIR DISKUS 54 44 74 65
CITALOPRAM HBR 53 0 75 17
LEVETIRACETAM 53 14 75 128
WARFARIN SODIUM 52 32 77 22
NIFEDIPINE ER 50 48 78 130
CHLORTHALIDONE 50 38 78 174
LANSOPRAZOLE 50 22 78 190
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.